Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Empirical Finance LLC

Empirical Finance LLC lowered its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 7.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 945 shares of the biotechnology company’s stock after selling 78 shares during the quarter. Empirical Finance LLC’s holdings in Axon Enterprise were worth $278,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. Avantax Advisory Services Inc. raised its stake in Axon Enterprise by 0.8% during the 1st quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock worth $1,659,000 after acquiring an additional 40 shares in the last quarter. Brookstone Capital Management lifted its holdings in shares of Axon Enterprise by 5.1% in the 1st quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock valued at $263,000 after purchasing an additional 41 shares during the last quarter. Envestnet Portfolio Solutions Inc. lifted its holdings in shares of Axon Enterprise by 1.1% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 3,997 shares of the biotechnology company’s stock valued at $1,033,000 after purchasing an additional 43 shares during the last quarter. CWM LLC boosted its position in shares of Axon Enterprise by 1.5% in the 2nd quarter. CWM LLC now owns 2,820 shares of the biotechnology company’s stock valued at $830,000 after purchasing an additional 43 shares during the period. Finally, Wealthspan Partners LLC grew its stake in Axon Enterprise by 4.9% during the 2nd quarter. Wealthspan Partners LLC now owns 965 shares of the biotechnology company’s stock worth $284,000 after buying an additional 45 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Up 0.8 %

AXON opened at $364.97 on Friday. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52. Axon Enterprise, Inc. has a 12 month low of $189.12 and a 12 month high of $378.89. The stock has a market capitalization of $27.58 billion, a P/E ratio of 106.72, a P/E/G ratio of 9.78 and a beta of 0.95. The business has a 50 day simple moving average of $325.12 and a 200-day simple moving average of $308.11.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. The company had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. Axon Enterprise’s quarterly revenue was up 34.5% compared to the same quarter last year. During the same quarter last year, the company earned $0.80 earnings per share. On average, equities analysts anticipate that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on AXON shares. Robert W. Baird increased their price objective on Axon Enterprise from $355.00 to $360.00 and gave the company an “outperform” rating in a report on Wednesday, August 7th. Craig Hallum increased their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Needham & Company LLC restated a “buy” rating and issued a $400.00 price objective on shares of Axon Enterprise in a research note on Wednesday, August 7th. JMP Securities reiterated a “market outperform” rating and set a $375.00 target price on shares of Axon Enterprise in a research note on Wednesday, August 7th. Finally, Barclays boosted their price target on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus price target of $358.08.

Insider Buying and Selling

In other Axon Enterprise news, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the transaction, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $373.03, for a total transaction of $167,863.50. Following the completion of the transaction, the director now owns 7,379 shares of the company’s stock, valued at approximately $2,752,588.37. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick W. Smith sold 80,300 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the sale, the chief executive officer now owns 3,015,366 shares in the company, valued at $1,121,052,771.48. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 152,750 shares of company stock valued at $56,105,818. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.